Publicaciones científicas

Urinary incontinence: new pharmacologic therapies

01-oct-2004 | Revista: Revista de Medicina de la Universidad de Navarra

Robles García JERosell Costa D, Berián Polo JM.

Departamento de Urología, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra.


Several classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI).

Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medication, Duloxetine, which appears to be clinically safe and effective for the treatment of SUI.

On the other hand, a new muscarinic receptor antagonist, Solifenacin, has been shown in clinical trials to be clinically effective, safe and well tolerated for treating OAB.

CITA DEL ARTÍCULO  Rev Med Univ Navarra. 2004 Oct-Dec;48(4):43-9

Nuestros autores